Skip to main
OPK

OPKO Health (OPK) Stock Forecast & Price Target

OPKO Health (OPK) Analyst Ratings

Based on 2 analyst ratings
Hold
Strong Buy 0%
Buy 50%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

OPKO Health is facing challenges in their diagnostics segment as reflected by its $13.0 million operating loss and lack of cost reductions. Although they had hoped to break even in Q4/25, this does not seem likely based on management's commentary and this quarter's annualized adjusted EBITDA loss of $36.4 million. Even the promising 4KScore test showed a decline in revenue from the previous year. This, combined with other factors such as the lack of cost and expense reductions, leads to a diminished outlook for the company in the near future.

Bears say

OPKO Health is facing challenges in meeting their financial guidance for FY/26 and may be unable to achieve the upper end of their revenue projections, causing concern. Additionally, their diagnostics business showed an operating loss in the quarter, despite expectations of at least breaking even. The company has potential for cost reduction but it is unclear if it will be enough to support profitable growth in 2026.

OPKO Health (OPK) has been analyzed by 2 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 50% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of OPKO Health and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About OPKO Health (OPK) Forecast

Analysts have given OPKO Health (OPK) a Hold based on their latest research and market trends.

According to 2 analysts, OPKO Health (OPK) has a Hold consensus rating as of Jun 3, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $1.55, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $1.55, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

OPKO Health (OPK)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.